Withanone and Withaferin-A are predicted to interact with transmembrane protease serine 2 (TMPRSS2) and block entry of SARS-CoV-2 into cells
暂无分享,去创建一个
S. Kaul | R. Wadhwa | J. Dhanjal | D. Sundar | Ashish Kaul | Vipul Kumar | Huayue Zhang | Priyanshu Bhargava | Jia Wang
[1] Y. Ahn,et al. Antiviral effects and possible mechanisms of action of constituents from Brazilian propolis and related compounds , 2020 .
[2] S. Kaul,et al. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity , 2020, Journal of biomolecular structure & dynamics.
[3] A. Hasan,et al. The expression level of angiotensin-converting enzyme 2 determines the severity of COVID-19: lung and heart tissue as targets , 2020, Journal of biomolecular structure & dynamics.
[4] A. Hasan,et al. Development of remdesivir repositioning as a nucleotide analog against COVID-19 RNA dependent RNA polymerase , 2020, Journal of biomolecular structure & dynamics.
[5] M. Hendaus. Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary , 2020, Journal of biomolecular structure & dynamics.
[6] Wen Zhang,et al. Inhibition of Influenza A virus propagation by benzoselenoxanthenes stabilizing TMPRSS2 Gene G-quadruplex and hence down-regulating TMPRSS2 expression , 2020, Scientific Reports.
[7] G. Gyebi,et al. Potential inhibitors of coronavirus 3-chymotrypsin-like protease (3CLpro): an in silico screening of alkaloids and terpenoids from African medicinal plants , 2020, Journal of biomolecular structure & dynamics.
[8] K. Kehn-Hall,et al. Alpha 1 Antitrypsin is an Inhibitor of the SARS-CoV-2-Priming Protease TMPRSS2 , 2020, bioRxiv.
[9] Ramesh Chandra,et al. Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures , 2020, Journal of biomolecular structure & dynamics.
[10] Tuğba Taşkın Tok,et al. Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2 , 2020, Journal of biomolecular structure & dynamics.
[11] Naún Lobo-Galo,et al. FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication , 2020, Journal of biomolecular structure & dynamics.
[12] Said Ghalem,et al. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria , 2020, Journal of biomolecular structure & dynamics.
[13] Chandrabose Selvaraj,et al. Identification of new anti-nCoV drug chemical compounds from Indian spices exploiting SARS-CoV-2 main protease as target , 2020, Journal of biomolecular structure & dynamics.
[14] S. Sinha,et al. An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets , 2020, Journal of biomolecular structure & dynamics.
[15] Sumra Wajid Abbasi,et al. Stilbene-based natural compounds as promising drug candidates against COVID-19 , 2020, Journal of biomolecular structure & dynamics.
[16] Nizam Uddin,et al. A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2 , 2020, Journal of biomolecular structure & dynamics.
[17] A. Elfiky,et al. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective , 2020, Journal of biomolecular structure & dynamics.
[18] Ashok P. Giri,et al. Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease , 2020, Journal of biomolecular structure & dynamics.
[19] Jerrine Joseph,et al. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach , 2020, Journal of biomolecular structure & dynamics.
[20] Adolfo B Poma,et al. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment , 2020, Journal of biomolecular structure & dynamics.
[21] Kemal Yelekçi,et al. Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes , 2020, Journal of biomolecular structure & dynamics.
[22] Hemant Kumar Srivastava,et al. Peptide-like and small-molecule inhibitors against Covid-19 , 2020, Journal of biomolecular structure & dynamics.
[23] M. Bouachrine,et al. Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations , 2020, Journal of biomolecular structure & dynamics.
[24] Sourav Das,et al. An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study , 2020, Journal of biomolecular structure & dynamics.
[25] Majid Sharifi,et al. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin , 2020, Journal of biomolecular structure & dynamics.
[26] Bikash Medhi,et al. In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain) , 2020, Journal of biomolecular structure & dynamics.
[27] Rajat Kumar Jha,et al. Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase , 2020, Journal of biomolecular structure & dynamics.
[28] M. Michael Gromiha,et al. Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19 , 2020, Journal of biomolecular structure & dynamics.
[29] Ramakrishna Vadde,et al. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel , 2020, Journal of biomolecular structure & dynamics.
[30] Reaz Uddin,et al. Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach , 2020, Journal of biomolecular structure & dynamics.
[31] Duong Tuan Quang,et al. Investigation into SARS-CoV-2 Resistance of Compounds in Garlic Essential Oil , 2020, ACS omega.
[32] A. Balkrishna,et al. Withanone from Withania somnifera May Inhibit Novel Coronavirus (COVID-19) Entry by Disrupting Interactions between Viral S-Protein Receptor Binding Domain and Host ACE2 Receptor , 2020 .
[33] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[34] W. Ko,et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges , 2020, International Journal of Antimicrobial Agents.
[35] H. Juan,et al. Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking , 2020 .
[36] Wei Zhang,et al. Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment. , 2020, Bioscience trends.
[37] Federico M Giorgi,et al. Genomic variance of the 2019‐nCoV coronavirus , 2020, Journal of medical virology.
[38] A. Chaillon,et al. Transmission dynamics and evolutionary history of 2019‐nCoV , 2020, Journal of medical virology.
[39] E. Holmes,et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding , 2020, The Lancet.
[40] Xiaomei Wang,et al. Potential of large “first generation” human‐to‐human transmission of 2019‐nCoV , 2020, Journal of medical virology.
[41] G. Panayiotakopoulos,et al. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event , 2020, bioRxiv.
[42] Y. Hu,et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China , 2020, The Lancet.
[43] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[44] M. Ciccozzi,et al. The 2019‐new coronavirus epidemic: Evidence for virus evolution , 2020, bioRxiv.
[45] Leon N. Schulte,et al. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes , 2019, Journal of Virology.
[46] Yukiko Shimizu,et al. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection , 2019, Journal of Virology.
[47] A. Kaur,et al. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost , 2018, PloS one.
[48] Yoshimasa Tanaka,et al. TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections , 2017, Biochimie.
[49] L. Naesens,et al. Airway proteases: an emerging drug target for influenza and other respiratory virus infections , 2017, Current Opinion in Virology.
[50] K. Dhama,et al. Immunomodulatory and prophylactic efficacy of herbal extracts against experimentally induced chicken infectious anaemia in chicks: assessing the viral load and cell mediated immunity , 2017, VirusDisease.
[51] S. Kaul,et al. Novel Methods to Generate Active Ingredients-Enriched Ashwagandha Leaves and Extracts , 2016, PloS one.
[52] Fang Li,et al. Structure, Function, and Evolution of Coronavirus Spike Proteins. , 2016, Annual review of virology.
[53] K. Shirato,et al. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry , 2016, Journal of Virology.
[54] S. Kaul,et al. Nootropic potential of Ashwagandha leaves: Beyond traditional root extracts , 2016, Neurochemistry International.
[55] Jennifer L. Knight,et al. OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins. , 2016, Journal of chemical theory and computation.
[56] R. Nagatomi,et al. The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells , 2015, Pulmonary Pharmacology & Therapeutics.
[57] Yanchen Zhou,et al. Protease inhibitors targeting coronavirus and filovirus entry , 2015, Antiviral Research.
[58] Zhi Cai,et al. Promising Anti-influenza Properties of Active Constituent of Withania somnifera Ayurvedic Herb in Targeting Neuraminidase of H1N1 Influenza: Computational Study , 2015, Cell Biochemistry and Biophysics.
[59] Navjot Shah,et al. Withanone-Rich Combination of Ashwagandha Withanolides Restricts Metastasis and Angiogenesis through hnRNP-K , 2014, Molecular Cancer Therapeutics.
[60] K. Shirato,et al. Middle East Respiratory Syndrome Coronavirus Infection Mediated by the Transmembrane Serine Protease TMPRSS2 , 2013, Journal of Virology.
[61] H. Klenk,et al. Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium , 2013, Pathogens and disease.
[62] Woody Sherman,et al. Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.
[63] H. Klenk,et al. Hemagglutinin activating host cell proteases provide promising drug targets for the treatment of influenza A and B virus infections. , 2012, Vaccine.
[64] G. Whittaker,et al. Mechanisms of Coronavirus Cell Entry Mediated by the Viral Spike Protein , 2012, Viruses.
[65] L. van der Hoek,et al. Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry , 2012, Journal of Virology.
[66] M. Thakur,et al. Protective Role of Ashwagandha Leaf Extract and Its Component Withanone on Scopolamine-Induced Changes in the Brain and Brain-Derived Cells , 2011, PloS one.
[67] Ramesh C. Gupta,et al. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. , 2011, Carcinogenesis.
[68] Y. Park. TMPRSS2 (transmembrane protease, serine 2) , 2011 .
[69] Christian Drosten,et al. Cleavage and Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by Human Airway Trypsin-Like Protease , 2011, Journal of Virology.
[70] K. Schughart,et al. Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection , 2011, Virology Journal.
[71] D. A. Stein,et al. Inhibition of Influenza Virus Infection in Human Airway Cell Cultures by an Antisense Peptide-Conjugated Morpholino Oligomer Targeting the Hemagglutinin-Activating Protease TMPRSS2 , 2010, Journal of Virology.
[72] Jincun Zhao,et al. A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry , 2010, Journal of Virology.
[73] Bert W O'Malley,et al. Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. , 2010, Molecular endocrinology.
[74] Markus Eickmann,et al. Cleavage of Influenza Virus Hemagglutinin by Airway Proteases TMPRSS2 and HAT Differs in Subcellular Localization and Susceptibility to Protease Inhibitors , 2010, Journal of Virology.
[75] H. Klenk,et al. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition. , 2009, Vaccine.
[76] Navjot Shah,et al. Deceleration of senescence in normal human fibroblasts by withanone extracted from ashwagandha leaves. , 2009, The journals of gerontology. Series A, Biological sciences and medical sciences.
[77] Nashi Widodo,et al. Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. , 2008, Cancer letters.
[78] Matthew P. Repasky,et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.
[79] P. Nelson,et al. Phenotypic Analysis of Mice Lacking the Tmprss2-Encoded Protease , 2006, Molecular and Cellular Biology.
[80] A. Zijlstra,et al. The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells. , 2005, The Biochemical journal.
[81] R. Hubert,et al. Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia. , 2001, Cancer research.
[82] L. Hood,et al. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. , 1999, Cancer research.
[83] M. Peitsch,et al. Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. , 1997, Genomics.
[84] J. Boustie,et al. Comparison of the anti-herpes simplex virus activities of propolis and 3-methyl-but-2-enyl caffeate. , 1994, Journal of natural products.
[85] J. Serkedjieva,et al. Anti-influenza virus effect of some propolis constituents and their analogues (esters of substituted cinnamic acids). , 1992, Journal of natural products.
[86] J. S. Kim,et al. Evaluation of anti-influenza effects of camostat in mice infected with non-adapted human influenza viruses , 2005, Archives of Virology.